AIM
MYOV

Axiom Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Axiom Investment Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$18K – 470
2022
Q3 		$18K Buy
+1,000
New +$16K 0.04% 231

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Axiom Investment Management's MYOV Position: Q4 2022 in Review

Axiom Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 1,000 shares — an estimated $18K sold.

Axiom Investment Management first reported a position in MYOV in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Axiom Investment Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 1,000 Myovant Sciences Ltd. shares in Q4 2022, an estimated $18K.
  • Axiom Investment Management first reported a position in Myovant Sciences Ltd. in Q3 2022 and held it in 1 quarter.
  • Axiom Investment Management's Myovant Sciences Ltd. position peaked at $18K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.